Olema Pharmaceuticals Inc (OLMA)
R&D Expense Growth
17.37%
Quarterly · Period ending:
OLMA R&D Expense Growth
Latest reported17.37%period ending
Latest reported17.37%period ending
OLMA Quarterly R&D Growth (QoQ) (0.00% → 17.37%)
Latest values, visible window
High-resolution chart · PNG
OLMA r&d expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| 17.3728% | |
| 13.9102% | |
| 8.1825% | |
| -8.9996% | |
| 43.3582% | |
| -5.1859% | |
| -2.79% | |
| 14.1434% | |
| -2.5901% | |
| 15.5032% | |
| 32.9975% | |
| 8.1383% | |
| -21.1907% | |
| 5.7543% | |
| 22.4485% | |
| -34.8451% | |
| 68.9924% | |
| 0.2128% | |
| 27.5653% | |
| 5.1469% | |
| 11.3917% | |
| 70.0111% | |
| 34.5816% | |
| 140.0103% | |
| 144.9057% | |
| -12.6374% | |
| 0% |